Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3

ID#: NCT06595030

Age: 55 years - 66+

Gender: All

Healthy Subjects: No

Study Phase: N/A

Recruitment Status: Recruiting

Start Date: December 03, 2024

End Date: January 31, 2027

Contact Information:
Barbara Plitnick, BSN
518-242-4603
Mariana Figueiro, PhD
212-241-6500
Summary: Investigate the long-term impact of amount and duration of Tailored Lighting Intervention (TLI) obtained from Aims 1 and 2 on sleep, cognition, circadian marker, mood, and behavior in AD/ADRD patients. For this single-arm, randomized, placebo-controlled study, the researchers plan to recruit 100 participants who will experience either the active TLI or the placebo for 6 months.
Eligibility:

Inclusion Criteria:

- Diagnosis of Alzheimer's disease or related dementia with a Montreal Cognitive Assessment score <25

- Sleep disturbance with a Pittsburgh Sleep Quality Index score ≥5

Exclusion Criteria:

- Extensive brain vascular disease, traumatic brain injury, multiple sclerosis, Parkinson's Disease

- Obstructing cataracts

- Severe macular degeneration

- Use of sleep medication

- Use of oral melatonin

- untreated moderate to severe sleep apnea

- Severe restless leg syndrome

- Blindness
Find a Clinical Trial Find Cancer Clinical Trials